Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Vaccines|October 28, 2023
<i>In Silico</i> Analyses, Experimental Verification and Application in DNA Vaccines of Ebolavirus GP-Derived pan-MHC-II-Restricted EpitopesJunqi Zhang, Baozeng Sun, Wenyang Shen, et al.
International Journal of Biological Sciences|January 10, 2022
HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m<sup>6</sup>A-MYC expressionChenchen Hu, Tianyue Liu, Chenying Han, et al.
International Immunopharmacology|May 18, 2025
Comparative immunobiology and cross-species validations of pan-MHC-II epitopes on Hantaan virus nucleocapsid proteinZhikui Li, Yubo Sun, Baozeng Sun, et al.
Frontiers in Immunology|March 20, 2026
Immunoreactivity of pan MHC-I epitopes on Crimean-Congo hemorrhagic fever virus glycoprotein C-terminalDongbo Jiang, Yongkai Wang, Haobo Kang, et al.
Frontiers in Cellular and Infection Microbiology|August 5, 2021
Integrative Analysis of HTNV Glycoprotein Derived MHC II Epitopes by <i>In Silico</i> Prediction and Experimental ValidationHao Sun, Zhenhua Lu, Guoyun Xuan, et al.
NPJ Vaccines|October 24, 2024
A comprehensive investigation of Glycoprotein-based nucleic acid vaccines for Hantaan VirusJiaxing Zhang, Junqi Zhang, Yanbo Wang, et al.
International Journal of Molecular Medicine|November 21, 2025
Comparative analysis of pan MHC‑I epitopes immunoreactivity on Hantaan virus nucleocapsid proteinZhikui Li, Weijie Ding, Yubo Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2024
Nanopore tweezers show fractional-nucleotide translocation in sequence-dependent pausing by RNA polymeraseIan C Nova, Jonathan M Craig, Abhishek Mazumder, et al.
Vaccines|August 29, 2024
DNA Vaccines Encoding HTNV GP-Derived Th Epitopes Benefited from a LAMP-Targeting Strategy and Established Cellular ImmunoprotectionDongbo Jiang, Junqi Zhang, Wenyang Shen, et al.
Investigational New Drugs|December 14, 2019
Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cellsJie Hu, Enxin Wang, Lei Liu, et al.
Pageof 7